147 related articles for article (PubMed ID: 23304081)
1. Incidence and survival of patients with small intestinal neuroendocrine tumours in a Danish NET center.
Hoej LB; Nykjær KM; Gronbaek H
ScientificWorldJournal; 2012; 2012():206350. PubMed ID: 23304081
[TBL] [Abstract][Full Text] [Related]
2. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
[TBL] [Abstract][Full Text] [Related]
3. Chilean Registry for Neuroendocrine Tumors: A Latin American Perspective.
Pinto MP; Muñoz Medel M; Carrillo D; Retamal IN; Bravo ML; Valenzuela Y; Nervi B; Sánchez C; Galindo H; Ibañez C; Peña J; Balmaceda C; Madrid J; Briones J; Torres J; Nilo F; Guarda FJ; Quintana JC; Orellana P; Mondaca S; Acevedo F; Vicentini D; Cordova-Delgado M; Owen GI; Garrido M
Horm Cancer; 2019 Feb; 10(1):3-10. PubMed ID: 30465145
[TBL] [Abstract][Full Text] [Related]
4. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
[TBL] [Abstract][Full Text] [Related]
5. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
[TBL] [Abstract][Full Text] [Related]
6. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Kipnis ST; Hung M; Kumar S; Heckert JM; Lee H; Bennett B; Soulen MC; Pryma DA; Mankoff DA; Metz DC; Eads JR; Katona BW
JAMA Netw Open; 2021 Mar; 4(3):e212274. PubMed ID: 33755166
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
[TBL] [Abstract][Full Text] [Related]
8. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A.
Ardill JE; Armstrong L; Smye M; Doherty R; McCance DR; Johnston BT
QJM; 2016 Feb; 109(2):111-5. PubMed ID: 25979268
[TBL] [Abstract][Full Text] [Related]
12. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
[TBL] [Abstract][Full Text] [Related]
13. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
14. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
15. Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.
Hauck L; Bitzer M; Malek N; Plentz RR
Scand J Gastroenterol; 2016 Jan; 51(1):55-9. PubMed ID: 26137871
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and prognosis of malignant small bowel tumors: Experience from a university hospital in Chile.
Silva F; Bustamante M; Latorre G; Flandez J; Montero I; Dukes E; Gandara V; Robles C; Uribe J; Iglesias A; Bellolio F; Molina ME; Migueles R; Urrejola G; Larach T; Besser N; Sharp A; Agüero C; Riquelme A; Vargas JI; Candia R; Monrroy H; De Simone F; Espino A
Gastroenterol Hepatol; 2024 May; 47(5):491-499. PubMed ID: 38331316
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
Snorradottir S; Asgeirsdottir A; Rögnvaldsson S; Jonasson JG; Björnsson ES
Cancer Epidemiol; 2022 Aug; 79():102197. PubMed ID: 35716441
[TBL] [Abstract][Full Text] [Related]
18. Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006.
Qubaiah O; Devesa SS; Platz CE; Huycke MM; Dores GM
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1908-18. PubMed ID: 20647399
[TBL] [Abstract][Full Text] [Related]
19. Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015.
Wyld D; Moore J; Tran N; Youl P
Asia Pac J Clin Oncol; 2021 Aug; 17(4):350-358. PubMed ID: 33567164
[TBL] [Abstract][Full Text] [Related]
20. Indication for liver transplantation in young patients with small intestinal NETs is rare?
Norlén O; Daskalakis K; Öberg K; Åkerström G; Stålberg P; Hellman P
World J Surg; 2014 Mar; 38(3):742-7. PubMed ID: 24233660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
